Here we demonstrate that perturbation of this iASPP/p53 complex in vivo disrupts the equilibrium between immunogenic versus tolerogenic cell death, with profound cell-intrinsic and non-cell-autonomous effects on the development of autoimmune disease and cancer. The gene discussed is TP53; the disease is autoimmune disease.